These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 19664737)

  • 1. Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?
    Haney EM; Warden SJ; Bliziotes MM
    Bone; 2010 Jan; 46(1):13-7. PubMed ID: 19664737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adverse skeletal effects of selective serotonin reuptake inhibitors.
    Tsapakis EM; Gamie Z; Tran GT; Adshead S; Lampard A; Mantalaris A; Tsiridis E
    Eur Psychiatry; 2012 Apr; 27(3):156-69. PubMed ID: 21295451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies.
    Haney EM; Warden SJ
    J Musculoskelet Neuronal Interact; 2008; 8(2):133-45. PubMed ID: 18622082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do SSRIs play a role in decreasing bone mineral density?
    Chen F; Hahn TJ; Weintraub NT
    J Am Med Dir Assoc; 2012 Jun; 13(5):413-7. PubMed ID: 22037240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression.
    Fernandes BS; Hodge JM; Pasco JA; Berk M; Williams LJ
    Drugs Aging; 2016 Jan; 33(1):21-5. PubMed ID: 26547857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Antidepressive Agents and Bone Mineral Density in Women: A Meta-Analysis.
    Schweiger JU; Schweiger U; Hüppe M; Kahl KG; Greggersen W; Jauch-Chara K; Fassbinder E
    Int J Environ Res Public Health; 2018 Jun; 15(7):. PubMed ID: 29966324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study.
    Feuer AJ; Demmer RT; Thai A; Vogiatzi MG
    Bone; 2015 Sep; 78():28-33. PubMed ID: 25940460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SSRIs, bone mineral density, and risk of fractures--a review.
    Schwan S; Hallberg P
    Eur Neuropsychopharmacol; 2009 Oct; 19(10):683-92. PubMed ID: 19541458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
    Zhou C; Fang L; Chen Y; Zhong J; Wang H; Xie P
    Osteoporos Int; 2018 Jun; 29(6):1243-1251. PubMed ID: 29435621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the serotonin transporter-linked polymorphic region genotype with lower bone mineral density.
    Lapid MI; Kung S; Frye MA; Biernacka JM; Geske JR; Drake MT; Jankowski MD; Clarke BL
    Transl Psychiatry; 2017 Aug; 7(8):e1213. PubMed ID: 28892067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Depression, Generalized Anxiety, and Selective Serotonin Reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging Adults.
    Calarge CA; Mills JA; Janz KF; Burns TL; Schlechte JA; Coryell WH; Zemel BS
    J Bone Miner Res; 2017 Dec; 32(12):2367-2374. PubMed ID: 28815738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
    Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM;
    Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of depression and its treatment on the bones of growing children.
    Weller EB; Weller RA; Kloos AL; Hitchcock S; Kim WJ; Zemel B
    Curr Psychiatry Rep; 2007 Apr; 9(2):94-8. PubMed ID: 17389117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant medications and osteoporosis.
    Rizzoli R; Cooper C; Reginster JY; Abrahamsen B; Adachi JD; Brandi ML; Bruyère O; Compston J; Ducy P; Ferrari S; Harvey NC; Kanis JA; Karsenty G; Laslop A; Rabenda V; Vestergaard P
    Bone; 2012 Sep; 51(3):606-13. PubMed ID: 22659406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bones of Contention: A Comprehensive Literature Review of Non-SSRI Antidepressant Use and Bone Health.
    Power C; Duffy R; Mahon J; McCarroll K; Lawlor BA
    J Geriatr Psychiatry Neurol; 2020 Nov; 33(6):340-352. PubMed ID: 31665962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal Bone Microstructure and Density But Worse Physical Function in Older Women Treated with Selective Serotonin Reuptake Inhibitors, a Cross-Sectional Population-Based Study.
    Larsson B; Mellström D; Johansson L; Nilsson AG; Lorentzon M; Sundh D
    Calcif Tissue Int; 2018 Sep; 103(3):278-288. PubMed ID: 29730704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant use and risk of adverse outcomes in people aged 20-64 years: cohort study using a primary care database.
    Coupland C; Hill T; Morriss R; Moore M; Arthur A; Hippisley-Cox J
    BMC Med; 2018 Mar; 16(1):36. PubMed ID: 29514662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of SSRIs on bone metabolism].
    Kerbage H; Bahadori S; Léger J; Carel JC; Purper Ouakil D
    Encephale; 2014 Feb; 40(1):56-61. PubMed ID: 23810751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.